Comparison of bleeding and in-hospital mortality in Asian-Americans versus Caucasian-Americans with ST-elevation myocardial infarction receiving reperfusion therapy.

[1]  Sunil V. Rao,et al.  Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy. , 2011, The American journal of medicine.

[2]  V. Sharma,et al.  Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore. , 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[3]  Xiaoying Li,et al.  Risk assessment and aspirin use in Asian and Western populations , 2010, Vascular health and risk management.

[4]  H. Krumholz,et al.  Choice of Reperfusion Strategy at Hospitals With Primary Percutaneous Coronary Intervention: A National Registry of Myocardial Infarction Analysis , 2009, Circulation.

[5]  Harlan M Krumholz,et al.  Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study , 2009, BMJ : British Medical Journal.

[6]  Ching-Lan Cheng,et al.  Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan. , 2008, Clinical therapeutics.

[7]  A. Yasunaga,et al.  Genetic Factors for Ischemic and Hemorrhagic Stroke in Japanese Individuals , 2008, Stroke.

[8]  T. Morimoto,et al.  Aspirin for primary prevention of atherosclerotic disease in Japan. , 2007, Journal of atherosclerosis and thrombosis.

[9]  K. Alexander,et al.  Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative. , 2007, The American journal of cardiology.

[10]  R. Califf,et al.  Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. , 2007, European heart journal.

[11]  David P Miller,et al.  Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.

[12]  Harlan M Krumholz,et al.  Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. , 2006, Journal of the American College of Cardiology.

[13]  R. Collins,et al.  Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[14]  J. Hochman,et al.  Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. , 2005, JAMA.

[15]  T. Tsoi,et al.  The Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Atrial Fibrillation , 2005, Cerebrovascular Diseases.

[16]  J. Hambleton,et al.  The Influence of Ethnicity on Warfarin Dosage Requirement , 2005, The Annals of pharmacotherapy.

[17]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[18]  G. Biondi-Zoccai,et al.  Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. , 2004, Journal of the American College of Cardiology.

[19]  O. Matsuo,et al.  The Differences in Thrombolytic Effects of Administrated Recombinant t-PA between Japanese and Caucasians , 2002, Thrombosis and Haemostasis.

[20]  K. Coyne,et al.  A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. , 2001, American heart journal.

[21]  W. Rogers,et al.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.